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ABSTRACT 
 
OBJECTIVE: The objective of this selective EBM review is to determine whether or not weight 
lifting is effective in reducing lymphedema in breast cancer survivors. 
 
STUDY DESIGN:  Systematic review of three English language primary studies published in 
2009 and 2010. 
 
DATA SOURCES:  Three single blind, randomized controlled trials comparing progressive 
weight lifting and other treatments in breast cancer survivors were found using the Cochrane 
Database of Systematic Reviews and PubMed. 
 
OUTCOMES MEASURED:  Incidence of breast cancer-related lymphedema onset measured by 
blinded certified lymphedema therapists using a standardized clinical evaluation derived from 
the Common Toxicity Criteria version 3.0, comprising of interlimb differences, patient 
symptoms, and variation in arm tissue tone or texture.  Incidence of lymphedema exacerbations 
measured by blinded certified lymphedema specialists using a standardized evaluation. Number 
and severity of lymphedema symptoms measured through participant-reported validated surveys 
evaluating the occurrence and severity of 14 lymphedema-related arm symptoms: rings too tight, 
watch too tight, bracelet too tight, clothing too tight, puffiness, knuckles or veins not visible, 
leathery skin, tired arms, pain, pitting, swelling after exercise, difficulty writing, or other.  Pain 
and heaviness sensation in affected arm measured with the visual analogue scale (VAS). Change 
in arm and hand swelling determined by water volume displacement.  
 
RESULTS:  Sagen et al (2009) did not find weight lifting to be effective in reducing 
lymphedema onset in breast cancer survivors.  Schmitz et al (2009) did find a significant 
relationship between weight lifting and reduced lymphedema exacerbations when considering 
evaluations by certified specialists and patient-reported validated surveys.  Schmitz et al (2010) 
did not show a significant relationship between weight lifting and reduced lymphedema when 
using clinician-defined lymphedema onset. 
 
CONCLUSIONS: The studies in this review provide inconclusive evidence in determining 
whether weight lifting is effective in reducing lymphedema in breast cancer survivors.  Future 
RCTs are needed to evaluate the efficacy of weight lifting and lymphedema. 
 
KEY WORDS:  Exercise, weight lifting, lymphedema, breast cancer
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INTRODUCTION 
 Lymphedema is a debilitating disorder and frequently feared consequence of breast 
cancer treatment.  The fundamental issue is lymphatic dysfunction in which proteins, lipids and 
water cannot be brought back to the intravascular space, causing abnormal buildup of interstitial 
fluid 1.  Upper extremity lymphedema often causes patients to restrict the use of their affected 
limb in the hopes of preventing or reducing symptoms, such as swelling, heaviness, and pain 2.  
However, limited use of the arm may actually increase the chance of injury and lymphedema 3. 
Lymphedema is a major concern among breast cancer survivors and health care providers 
because it is a chronic and progressive disorder.  It specifically causes physical problems, 
emotional stress, and a significant impact on quality of life.  Currently, there are over 2.4 million 
breast cancer survivors in the Unites States, with nearly 184,000 American women diagnosed 
with breast cancer yearly 2.  About 61% of breast cancer patients have sentinel lymph node 
biopsy performed, with 5-7% forming lymphedema.  Furthermore, one-third of breast cancer 
patients undergo complete axillary dissection, with lymphedema developing in 13-47% 3.   
Research shows that women with breast cancer-related lymphedema have considerably 
higher two-year, post-operative medical costs than breast cancer patients without lymphedema.  
The rise in cost ranges from $14,877 to $23,167, and is due to office visits, prescription 
medication, treatment for infections, mental health services, and diagnostic testing.  These 
patients also experience more interrupted days for hospitalization or office visits at 58.7 days 
within two years, compared to 46.5 days within two years for survivors without lymphedema 4. 
Currently, there is no known cure for lymphedema 4.  However, what is known about this 
high-protein edematous disorder is that the interstitial high oncotic pressure state promotes 
further buildup of water. As a result, the surrounding outflow tracts significantly dilate, valves 
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become nonfunctional, and lymphatic walls turn fibrotic.  An inflammatory reaction takes place, 
leading to major risk of chronic infection, as well as the distinguishing change from initial pitting 
edema to nonpitting lymphedema 1.  There are many risk factors for upper extremity 
lymphedema, including breast cancer treatment with axillary node dissection, chemotherapy, and 
breast or axillary radiation, as well as high BMI, injuries, infections, increased amount of lymph 
nodes affected by the tumor, and surgical intervention on the dominant or non-dominant limb 4,5. 
Lymphedema treatment includes symptom relief, proper skin hygiene, manual lymphatic 
drainage, elastic compression garments, pneumatic pumps, multilayer bandaging, and palliative 
surgical therapy 1,4.  Although research indicates that exercise is beneficial for breast cancer 
survivors and holds no increased risk of lymphedema, health care providers frequently encourage 
physical activity restrictions of the affected extremity during rehabilitation 5.  Since restricting 
upper extremity movement may hinder recovery and decondition the arm, weight lifting may 
enhance physical-work ability and protect the limb during routine daily activities.  It is theorized 
that progressive weight lifting either combined with or used as an alternative to current therapy 
may reduce the onset of lymphedema symptoms and incidence of exacerbations 2,3. 
OBJECTIVE 
 The objective of this selective EBM review is to determine whether or not weight lifting 
is effective in reducing lymphedema in breast cancer survivors.  
METHODS 
 Included in this analysis were three single blind, randomized controlled trials (RCTs) all 
of which compared weight lifting to other treatments.  The population studied was female breast 
cancer survivors.  The intervention used was progressive weight lifting and the comparison was 
either no weight lifting or change in baseline exercise level, or activity restrictions combined 
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with usual care program without a weight lifting intervention.  To measure outcomes, various 
methods were used including lymphedema onset and diagnosis, change in arm and hand 
swelling, incidence of lymphedema exacerbations, and number and severity of symptoms.  
 A detailed inquiry was performed by the author of this review between December 2010 
and February 2011 using the Cochrane Database of Systematic Reviews and PubMed.  The key 
words “exercise,” “weight lifting,” “lymphedema,” and “breast cancer” were used in 
combinations to search for articles.  The RCTs chosen were published in English and in peer-
review journals from 2009-2010.  Articles were selected based on their relevance and the 
importance of outcomes to the patient (Patient Oriented Evidence that Matters, or POEMs).  
Studies included in this review were three RCTs published after 1996, all of which included 
patient oriented outcomes.  The exclusion criteria consisted of male patients, participants under 
age 18, breast cancer patients who did not undergo lymph node dissection, or regimens that did 
not involve upper body progressive weight training.  The statistics utilized were relative risk 
reduction (RRR), absolute risk reduction (ARR), relative benefit increase (RBI), absolute benefit 
increase (ABI), number needed to treat (NNT), 95% confidence interval, and p-value.  Table 1 
represents the demographics and characteristics of included studies. 
Table 1- Demographics & characteristics of included studies 2,3,5 
Study Type # Pts Age 
(yrs) 
Inclusion Criteria Exclusion Criteria W/D Interventions 
Sagen,  
2009 
RCT 207 32-75 
(mean- 
55) 
Women w/ Hx of early-
stage breast ca & 
mastectomy or breast-
conserving surgery with 
axillary node 
dissection, with or 
without radiotherapy, 
chemotherapy, or 
hormone therapy  
Age > 75 yrs, 
difficulty 
understanding 
Norwegian, and 
presence of 
metastasized breast 
cancer, other types of 
cancer, injury, poor 
functioning of upper 
limb 
3 No activity 
restrictions 
(NAR) in daily 
living combined 
with a moderate 
resistance 
exercise 
program for 6 
months 
Schmitz, 
2009 
RCT 141 Age > 
18 
(mean-
56; 58)  
Women w/ Hx of 
unilateral non-mets 
breast ca dx 1-15 yrs 
before study entry, BMI 
Hx of B/L ca, current 
ca, moved away, no 
LN removed, 
received dx w/in 
11 One-year 
progressive 
weight lifting 
regimen 
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< 50kg/m2, no current 
evidence of ca, no 
medical conditions 
limiting exercise, > 1 
LN removed, clinical 
dx of stable breast ca-
related lymphedema 
previous yr or > 15 
yrs before study 
entry, medical 
contraindication, 
currently weight 
lifting or enrolled in 
weight loss program, 
did not have 
lymphedema 
Schmitz, 
2010 
RCT 
 
154 36-75 
(mean-
54; 56) 
Women w/ Hx of U/L 
non-mets breast ca dx 
1-5 yrs before study 
entry, BMI < 50kg/m2, 
cancer free, no medical 
conditions limiting 
exercise, no plans for 
surgery or to be away > 
1 month, > 2 LN 
removed, no prior dx of 
lymphedema, currently 
no lymphedema 
Hx of B/L ca, current 
ca, moved away, < 2 
nodes removed, dx 
w/ in 1 yr or >5 yrs 
before study entry, 
medical 
contraindication, 
currently weight 
lifting or enrolled in 
weight loss program, 
had lymphedema 
20 One-year 
progressive 
weight lifting 
regimen 
 
OUTCOMES MEASURED 
 The main outcome for Sagen et al (2009) was Voldiff (in ml) or the volume difference of 
the affected and control arms using the Simplified Water Displacement Instrument.  The other 
primary outcome included pain and heaviness sensation in the affected arm during physical 
activity using the visual analogue scale (VAS) 5.  The outcomes measured by Schmitz et al 
(2009) consisted of frequency of lymphedema exacerbations determined by blinded certified 
lymphedema specialists using a standardized evaluation, as well as number and severity of 
lymphedema symptoms measured through participant-reported validated surveys evaluating the 
occurrence and severity of 14 lymphedema-related arm symptoms (rings too tight, watch too 
tight, bracelet too tight, clothing too tight, puffiness, knuckles or veins not visible, leathery skin, 
tired arms, pain, pitting, swelling after exercise, difficulty writing, or other). The authors also 
examined difference in arm and hand swelling at one year, comparing the affected and 
unaffected arms through displaced water volume 2.  The main outcome for Schmitz et al (2010) 
was clinician-defined breast cancer-related lymphedema onset measured by blinded certified 
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lymphedema therapists using a standardized clinical evaluation derived from the Common 
Toxicity Criteria version 3.0, comprising of interlimb differences, patient symptoms, and 
variation in arm tissue tone or texture.  The authors also measured lymphedema onset as 5% or 
greater increase in arm swelling through water volume displacement 3.  
RESULTS 
 All three studies were RCTs in which the outcome assessors, clinicians and study 
workers were kept blind.  The exercise intervention for all three experiments took place at 
outpatient clinics or fitness centers.  In the experiment performed by Sagen et al (2009), a portion 
of the results was reported in dichotomous format, with the rest as continuous data.  Results 
reported by Schmitz et al (2009) and Schmitz et al (2010) were presented in dichotomous format. 
 Sagen et al (2009) found that at two years post surgery, 13% of both the no activity 
restriction (NAR) group and activity restriction (AR) group had arm lymphedema (87% of both 
NAR and AR groups without lymphedema onset).  The RRR and ARR were both calculated to 
be 0%.  NNT was determined to be 0, indicating that the outcome was random, with no relation 
between weight lifting and reduced lympedema onset (Table 2).  The Voldiff (in ml) at two years 
for NAR and AR were not significantly different, with mean measurements of NAR at 52 ml (± 
153) and AR at 82 ml (± 165).  The VAS ratings of pain and sensation of heaviness for NAR and 
AR were not significantly different at two years after surgery (p-value > 0.05).  Regarding the 
NAR participants, 61% had no pain, 24% experienced pain between 1 and 20mm, and 15% had 
pain above 21mm.  For the AR group, 64% had no pain, while 17% experienced pain between 1 
and 20mm and 17% had pain greater than 21mm on the VAS at two-year follow-up (Table 3) 5. 
Table 2-  Efficacy of weight lifting in prevention of lymphedema 3,5 
Study CER EER RRR ARR NNT 95% CI p-value 
Sagen, 2009 87% 87% 0% 0% 0 N/A N/A 
Schmitz, 2010 95.6% 98.5% 0.03% 2.9% 35  0.04-3.22 0.12 
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Table 3- Visual analogue scale (VAS) ratings of pain and heaviness in affected limb for NAR 
and AR at two-year follow-up for Sagen et al (2009) 
VAS No Pain, 0 mm  Pain, 1-20 mm  Pain, > 21mm  
NAR 61% 24% 15% 
AR 64% 17% 17% 
  
Schmitz et al (2009) reported a lower incidence of lymphedema exacerbations for the 
weight lifting group at 14%, compared to the control group at 29% as determined by the certified 
lymphedema specialists using standardized evaluations (86% of the weight lifting group and 
71% of the control group without lymphedema exacerbations).  The difference in frequency of 
lymphedema exacerbations was statistically significant with a 95% confidence interval of 0.23 to 
0.97 and p-value of 0.04.  The RBI was calculated to be 0.211%, the ABI was 15%, and NNT 
was 7.  This NNT value indicates that for every seven patients who followed the weight lifting 
treatment, there was one fewer incidence of lymphedema exacerbations compared to control 
(Table 4).  The authors also found that the percentage of participants who had an increase in limb 
swelling by 5% or greater were statistically similar between the weight lifting and control 
groups.  About 11% of the weight lifting group and 12% of the control group had an increase in 
limb swelling by 5% or more, with a 95% confidence interval of 0.88 to 1.13 and p-value of 
1.00.  Furthermore, Schmitz et al (2009) determined that the weight lifting group had 
significantly greater improvements in severity of lymphedema symptoms as measured through 
self-reported validated surveys, with a 95% confidence interval of -0.54 to -0.03 and p-value of 
0.03.  However, the difference between the two groups regarding change in the number of 
symptoms measured through the self-reported validated surveys was not statistically significant, 
with a 95% confidence interval of -1.32 to 0.06 and p-value of 0.07 (Table 5) 2. 
Table 4-  Efficacy of weight lifting in treatment of lymphedema 2 
Study CER EER RBI ABI NNT 95% CI p-value 
Schmitz, 2009 71% 86% 0.211% 15% 7 0.23–0.97 0.04 
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Table 5- Change in severity and number of lymphedema symptoms between weight lifting and 
control groups through self-reported validated surveys for Schmitz et al (2009) 
Variable 95% CI p-value 
Change in severity of symptoms, 
weight lifting vs. control 
-0.54- -0.03 0.03 
Change in number of symptoms, 
weight lifting vs. control 
-1.32- 0.06 0.07 
 
Schmitz et al (2010) reported that the percentage of participants who had clinician-
defined breast cancer-related lymphedema onset was similar between the weight lifting and 
control groups.  About 1.5% of the weight lifting group and 4.4% of the control had clinician-
defined onset (98.5% of the weight lifting group and 95.6% of the control group without 
lymphedema onset).  The difference between these two groups was not statistically significant 
with a 95% confidence interval of 0.04 to 3.22 and p-value of 0.12. The RRR was calculated to 
be 0.03% and ARR was 2.9%.  NNT was determined to be 35, indicating that for every 35 
patients who followed the weight lifting treatment, there was one fewer incidence of 
lymphedema onset compared to control (Table 2).  The authors also found that the percentage of 
participants who had an increase in limb swelling by 5% or greater were statistically different 
between the weight lifting and control groups.  There was a lower incidence of lymphedema 
onset for the weight lifting group at 11%, compared to the control at 17%, as determined by 
water volume displacement.  The difference in frequency of lymphedema onset was statistically 
significant with a 95% confidence interval of 0.28 to 1.45 and p-value of 0.003.  Schmitz et al 
(2010) performed a secondary analysis restricted to participants with 5 or more lymph nodes 
removed. The authors reported that about 2.4% of the weight lifting group and 6.5% of the 
control had clinician-defined lymphedema onset. The difference between these groups was not 
statistically significant with a 95% confidence interval of 0.04 to 3.38 and p-value of 0.13.  They 
also found a lower incidence of lymphedema onset for the weight lifting group at 7%, compared 
to the control at 22%, defined as 5% or greater increase in arm swelling determined by water 
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volume displacement. The difference in frequency of lymphedema onset was statistically 
significant with a 95% confidence interval of 0.09 to 1.00 and p-value of 0.001 (Table 6) 3. 
Table 6-  Lymphedema onset in patients with > 5 lymph nodes removed for Schmitz et al (2010)  
 Weight Lifting Control 95% CI p-value 
> 5% increase in arm swelling 7% 22% 0.09-1.00 0.001 
Clinician-defined onset 2.4% 6.5% 0.04-3.38 0.13 
 
The included studies required a history of nonmetastatic breast cancer in women.  
Participants in the study by Sagen et al (2009) were randomized into either the no activity 
restrictions (NAR) group with moderate resistance exercise training for six months or the control 
group with physical activity restrictions (AR) of the affected limb for six months.  The AR 
participants were instructed to refrain from strenuous physical activities or lifting objects with a 
weight greater than 3kg.  The study began with 207 participants with a clinical diagnosis of 
breast cancer and complete axillary node dissection.  Two women were excluded because they 
were found to not have node dissection and one woman was excluded because her baseline 
measurements were unintentionally deleted from the databank.  There were 52 missing 
participants at the two-year follow-up for several reasons: 14 women died, three moved to 
another location, 13 could not be contacted with the provided information, seven refused to 
participate, four were too frail or ill to continue, two control participants had axillary node 
dissection, and nine were lost to follow-up for reasons not mentioned.  Program adherence for 
the NAR group was 83% with a mean duration of attendance at 21 ± 4.8 weeks, while program 
adherence for the AR group was 89% with a mean duration of attendance at 22 ± 5.2 weeks 5.  
For Schmitz et al (2009), the participants were randomized into either a one-year 
progressive weight lifting regimen or a control group in which participants were instructed to 
maintain their baseline exercise level.  The study began with 141 participants with a diagnosis of 
stable breast cancer-related lymphedema.  Nine women were lost to follow-up and two withdrew 
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due to a second primary or recurrent cancer.  The median attendance rates for the weight lifting 
intervention in the first, second, third and fourth quarters were 96%, 88%, 81%, and 75% 2.   
Participants in the study by Schmitz et al (2010) were randomized into either a one-year 
progressive weight lifting regimen or a control group in which participants were asked not to 
alter baseline level of exercise during the study.  The study began with 154 participants at risk 
for lymphedema at baseline, with 13 women lost to follow-up and 7 withdrawing due to 
recurrent cancer.  The median attendance of the weight lifting group was 79%, including those 
lost to follow-up.  Schmitz et al (2010) included a special subset analysis of women with 5 or 
more lymph nodes removed to remain uniform with their earlier research and because majority 
of published research consists of sentinel lymph node biopsies with resection of 1 to 4 nodes 3.   
In the experiment performed by Sagen et al (2009), adverse events took place in three out 
of 104 participants from the intervention group: “two participants developed adhesive capsulitis 
with progressive immobilization and one patient developed supraspinatus tendinopathy.”  The 
authors take note of the high possibility that one of these patients had latent frozen shoulder just 
prior to study entry 5.  Schmitz et al (2009) denied any serious adverse events related to the 
weight lifting intervention, and Schmitz et al (2010) did not report adverse events.  
DISCUSSION 
 The Position Statement of the National Lymphedema Network in December 2011 
provides an update regarding lymphedema and exercise.  The organization states that 
lymphedema patients may participate in progressive weight lifting exercises through lifting body 
weight or objects with caution, in either an isometric or isotonic manner.  The guidelines 
recommend that patients begin with lighter weights, lower number of repetitions, and gradual 
progression in intensity.  The organization advises that patients should consult with a qualified 
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lymphedema specialist and personal trainer, allow enough time for rest in between sets, avoid 
weights that may constrict the limb, wear compression garments during exercise, stay hydrated, 
avoid overheating, and rotate which body parts are being worked during a session 6.  Prior 
research has shown that both physical activity and the associated rise in pulmonary effort 
increases lymph flow and enhances protein resorption.  Also, greater muscle strength may lower 
the impact of daily stresses to the affected extremity.  Other positive factors regarding 
progressive weight lifting include its wide availability at community fitness centers throughout 
the United States and its affordability.  However, it is important to acknowledge that the National 
Lymphedema Network 2005 guidelines stated that strength training is a form of exercise holding 
the highest risk to lymphedema patients 2.  Although recent research has demonstrated the 
healthy effects of exercise on lymphedema patients, many health care providers still recommend 
limited activity of the affected extremity as a precaution against developing lymphedema 5. 
 The study by Sagen et al (2009) did not show a significant relationship between weight 
lifting and reduced lymphedema onset in breast cancer survivors.  The data found by Schmitz et 
al (2009) suggest a significant relationship between weight lifting and reduced lymphedema 
exacerbations when considering evaluations by certified specialists and patient-reported 
validated surveys.  However, the relationship was not significant when using the gold standard of 
water displacement.  The experiment by Schmitz et al (2010) did not show a significant 
relationship between weight lifting and reduced lymphedema when using clinician-defined 
lymphedema onset. However, there was a significant relationship between weight lifting and 
reduced onset of lymphedema when using the gold standard of measuring water displacement.  
 A major limitation, which applied to each study, was that the participants could not be 
blinded due to the fact that they knew whether or not they were in the weight lifting group.  This 
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fact posed a risk for accidental disclosure of which group a patient belonged to. Another 
limitation for Sagen et al (2009) was the number of participants lost at the two-year follow-up: 
36 in the NAR group and 16 in the AR group.  A potential weakness specifically mentioned in 
the experiment by Schmitz et al (2009) is that the lymphedema exacerbations were examined by 
six certified therapists, rather than just one, which leaves room for inconsistency.  Another 
limitation is that the intervention participants may have revealed their recent weight lifting 
during evaluations for possible exacerbations, resulting in biased assessments.  A potential 
limitation in the experiment by Schmitz et al (2010) is that the intervention group participants 
may have disclosed their recent exercise during the evaluation sessions for lymphedema onset.  
 All three experiments demonstrated strengths such as high adherence rates, as previously 
mentioned.  Additionally, each intervention took place over a relatively longer period of time.  
Lastly, although the trials looked at different patient oriented outcomes, each study also used the 
gold standard of displaced water volume to evaluate lymphedema. 
CONCLUSION 
 The studies in this review provide inconclusive evidence in determining whether weight 
lifting is effective in reducing lymphedema in breast cancer survivors.  Future studies are needed 
to evaluate the efficacy of weight lifting and lymphedema.  Since there were variations in the 
methods reviewed, future trials should use a larger sample size, examine weight lifting alone as 
the intervention without the combination of other modalities, and follow a control that requires 
no change in the individual’s baseline.  Also, efforts should be made to use a weight lifting 
regimen that is standardized in the gradual progression and frequency of exercise.  However, 
studies are currently underway to determine the relationship between lymphedema treatment and 
the impact on symptoms and quality of life 7. 
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